* Viemed Healthcare Inc VMD.TO VMD.TO is expected to show a
fall in quarterly revenue when it reports results on November
1.
* The Lafayette, Louisiana-based company is expected to report
a 17.1% decrease in revenue to $27.744 million from $33.45
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Viemed Healthcare Inc
is for earnings of 4 cents per share. For the same quarter last
year, the company reported earnings of 7 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Viemed
Healthcare Inc is C$14.5, about 60.5% above its last closing
price of $5.73.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 30 2021 0.03 0.03 0.04 Beat 20
Mar. 31 2021 0.06 0.06 0.04 Missed -29.4
Dec. 31 2020 0.04 0.03 0.12 Beat 300
Sep. 30 2020 0.08 0.08 0.07 Missed -8.7
Jun. 0.23 0.23 0.48 Beat 108.7
30 2020
Mar. 31 2020 0.08 0.08 0.11 Beat 37.5
Dec. 31 2019 0.07 0.06 Missed -14.3
Sep. 30 2019 0.06 0.06 0.07 Beat 16.7
This summary was machine generated October 30 at 02:05 GMT. All
figures in US dollars unless otherwise stated